GSK Precision Cancer Consortium Launches With Bayer, GSK, Roche, Novartis as Founding Members The organization of pharmaceutical and biotechnology firms aims to increase access to genomic testing for cancer patients. 23andMe Gets $50M Payment as GSK Extends Companies' Drug Discovery Alliance The companies are using 23andMe's extensive genotype-phenotype database and other resources to identify targets for personalized therapeutics, continuing an alliance begun in 2018. UK Biobank WGS Consortium Describes 150K Genome Dataset at ASHG, Sets Sights on 500K Premium Researchers described the variant, disease, drug target, and drug safety insights being gained analyzing more than 150,000 UK Biobank whole-genome sequences. COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020 The pace of development for CRISPR-based infectious disease assays increased as the pandemic progress Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients. Dec 7, 2020 UK Biobank Collaborating With Biopharmas to Profile Plasma Proteome of 53K Subjects Nov 11, 2020 Adaptive Biotechnologies, GlaxoSmithKline Collaborate on MRD Testing Oct 21, 2020 UK Biobank Exomes Reveal Loss-of-Function Variants, Potential Disease Ties Oct 7, 2020 Nvidia Expands Genomics Activities With Supercomputer, New Partnerships Premium Jul 28, 2020 Startup CRISPR Firm Caspr Biotech Developing COVID Dx Using New Extremophile Bacteria Nuclease Premium May 20, 2020 Mammoth Biosciences, GSK Developing CRISPR-Based SARS-CoV-2 Diagnostic for Home Testing Premium Apr 30, 2020 GSK Gets Broad Zejula Indication in Ovarian Cancer; FDA Deems Myriad Genetics' Test Complementary Apr 8, 2020 Novacyt, AstraZeneca, GSK, University of Cambridge Partner to Increase SARS-CoV-2 Testing in UK Jan 23, 2020 Myriad Genetics Seeks Supplemental Approval of HRD Test as CDx for GSK Ovarian Cancer Drug Oct 29, 2019 FDA Approval of Myriad Genetics CDx Adds HRD to Growing List of Ovarian Cancer Predictive Markers Premium Oct 28, 2019 Study Finds Residual Protein Expression Common After CRISPR Knockout Oct 23, 2019 FDA Approves GSK's Zejula Alongside Myriad Genetics CDx for Advanced Ovarian Cancer Sep 11, 2019 UK Biobank Whole-Genome Sequencing Project Obtains £200M from Pharma, Government, Philanthropy Jun 24, 2019 SpeeDx, GSK Sign Test Supply, Development Deal Jun 13, 2019 GlaxoSmithKline, UC's Doudna Establish $67M Genomics, CRISPR Research Lab Apr 9, 2019 Myriad Submits MyChoice HRD as Companion Diagnostic for GSK's Zejula Mar 25, 2019 UK Biobank to Make Whole-Genome Sequencing Data on 500K-Sample Repository Publicly Available Premium Jan 25, 2019 In Brief This Week: Illumina, Novacyt, Twist Bioscience, iGene Laboratory, More Jul 26, 2018 GSK, 23andMe Gamble on Personalized Drug Discovery With Exclusive Deal Premium Jul 25, 2018 23andMe, GSK Ink Exclusive Drug Target Discovery Pact Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.